B细胞-话题@MedSci

#B细胞#

314篇内容 | 3079人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273155, encodeId=484a12e3155b2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, objectType=article, longId=37556, objectId=87f43e55666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87f43e55666, replyNumber=0, likeNumber=26, createdTime=2014-07-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87f43e55666, moduleTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87f43e55666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273154, encodeId=cecf12e3154f5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用, objectType=article, longId=37516, objectId=fc583e51605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc583e51605, replyNumber=0, likeNumber=27, createdTime=2014-07-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc583e51605, moduleTitle=CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc583e51605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273153, encodeId=b3ff12e315306, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nat Rev Cancer：骨粘连蛋白的丧失导致自体免疫B细胞的转化, objectType=article, longId=35471, objectId=dbdd354e1f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbdd354e1f0, replyNumber=0, likeNumber=27, createdTime=2014-05-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbdd354e1f0, moduleTitle=Nat Rev Cancer：骨粘连蛋白的丧失导致自体免疫B细胞的转化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbdd354e1f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273152, encodeId=d87f12e3152c4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=弥漫大B细胞淋巴瘤中枢神经系统侵犯的预防与治疗, objectType=article, longId=33953, objectId=675733953c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=675733953c3, replyNumber=0, likeNumber=38, createdTime=2014-05-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=675733953c3, moduleTitle=弥漫大B细胞淋巴瘤中枢神经系统侵犯的预防与治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=675733953c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273151, encodeId=57eb12e315157, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=MYC基因异常的侵袭性B细胞淋巴瘤, objectType=article, longId=33867, objectId=96593386e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96593386e81, replyNumber=0, likeNumber=30, createdTime=2014-04-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96593386e81, moduleTitle=MYC基因异常的侵袭性B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96593386e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273150, encodeId=0bb512e315014, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, objectType=article, longId=32508, objectId=f0633250802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0633250802, replyNumber=0, likeNumber=36, createdTime=2014-03-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0633250802, moduleTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0633250802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273149, encodeId=07e712e3149a3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nature：科学家首次证实肠道细菌能显著影响B细胞发育, objectType=article, longId=23275, objectId=3fe6232e510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fe6232e510, replyNumber=0, likeNumber=39, createdTime=2013-08-24, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fe6232e510, moduleTitle=Nature：科学家首次证实肠道细菌能显著影响B细胞发育, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fe6232e510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273148, encodeId=7b8b12e31484f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后, objectType=article, longId=19867, objectId=f5a31986eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5a31986eb7, replyNumber=0, likeNumber=29, createdTime=2013-06-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5a31986eb7, moduleTitle=ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5a31986eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273147, encodeId=7b8b12e3147a4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案, objectType=article, longId=18504, objectId=5cd51850457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cd51850457, replyNumber=0, likeNumber=35, createdTime=2013-05-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cd51850457, moduleTitle=The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cd51850457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273146, encodeId=4f5f12e3146c0, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗, objectType=article, longId=17564, objectId=f53c1e56400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f53c1e56400, replyNumber=0, likeNumber=44, createdTime=2013-04-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f53c1e56400, moduleTitle=NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f53c1e56400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273145, encodeId=f72812e31451a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）, objectType=article, longId=11320, objectId=310a11320c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=310a11320c6, replyNumber=0, likeNumber=39, createdTime=2012-11-28, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=310a11320c6, moduleTitle=Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=310a11320c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273144, encodeId=d91312e314453, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=STM：灵长类动物是研究HIV疫苗B细胞反应的模型, objectType=article, longId=7879, objectId=9036e8793c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9036e8793c, replyNumber=0, likeNumber=38, createdTime=2012-07-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9036e8793c, moduleTitle=STM：灵长类动物是研究HIV疫苗B细胞反应的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9036e8793c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273143, encodeId=927b12e314369, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Cancer Res.:抑制Stat3可强化对B细胞恶性肿瘤的免疫, objectType=article, longId=7400, objectId=8953e4004c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8953e4004c, replyNumber=0, likeNumber=48, createdTime=2012-06-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8953e4004c, moduleTitle=Cancer Res.:抑制Stat3可强化对B细胞恶性肿瘤的免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8953e4004c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273142, encodeId=af2c12e31429c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后, objectType=article, longId=7374, objectId=d039e37452, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d039e37452, replyNumber=0, likeNumber=35, createdTime=2012-06-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d039e37452, moduleTitle=JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d039e37452)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273141, encodeId=04c812e31413e, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Cancer Cell：弥散性大B细胞淋巴瘤协同性化疗新进展, objectType=article, longId=7187, objectId=1458e1872c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1458e1872c, replyNumber=0, likeNumber=26, createdTime=2012-06-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1458e1872c, moduleTitle=Cancer Cell：弥散性大B细胞淋巴瘤协同性化疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1458e1872c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273140, encodeId=c24312e3140c9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Science：细胞内随机性竞争决定B细胞命运, objectType=article, longId=3705, objectId=445e3e050f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=445e3e050f, replyNumber=0, likeNumber=33, createdTime=2012-01-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=445e3e050f, moduleTitle=Science：细胞内随机性竞争决定B细胞命运, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=445e3e050f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273139, encodeId=96b612e3139c7, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=利妥昔单抗联合苯达莫司汀或可治疗侵袭性B细胞淋巴瘤, objectType=article, longId=3000, objectId=35133000eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35133000eb, replyNumber=0, likeNumber=33, createdTime=2011-08-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35133000eb, moduleTitle=利妥昔单抗联合苯达莫司汀或可治疗侵袭性B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35133000eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273138, encodeId=600812e31386e, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=病例报道:原发纵隔大B细胞淋巴瘤一例, objectType=article, longId=2133, objectId=e3a221335f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3a221335f, replyNumber=0, likeNumber=30, createdTime=2010-09-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3a221335f, moduleTitle=病例报道:原发纵隔大B细胞淋巴瘤一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3a221335f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展

2014-07-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CSMO 2014：朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用

2014-07-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nat Rev Cancer：骨粘连蛋白的丧失导致自体免疫B细胞的转化

2014-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

弥漫大B细胞淋巴瘤中枢神经系统侵犯的预防与治疗

2014-05-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

MYC基因异常的侵袭性B细胞淋巴瘤

2014-04-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率

2014-03-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nature：科学家首次证实肠道细菌能显著影响B细胞发育

2013-08-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

ASCO 2013：新型生物标记物可用于弥漫大B细胞淋巴瘤分子分型及预后

2013-06-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

The Lancet：R-CHOP-21方案仍是新诊弥漫大B细胞淋巴瘤患者的标准一线方案

2013-05-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NEJM：利妥昔单抗方案治疗纵隔B细胞淋巴瘤可避免放疗

2013-04-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet Oncol：R-MegaCHOEP方案无益于年轻高危侵袭性B细胞淋巴瘤患者（(DSHNHL 2002-1研究）

2012-11-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

STM：灵长类动物是研究HIV疫苗B细胞反应的模型

2012-07-18

zhouqu_8 (审核中...)

前往app查看评论内容

#B细胞#

Cancer Res.:抑制Stat3可强化对B细胞恶性肿瘤的免疫

2012-06-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

JCO：MYC和BCL2蛋白高表达可预测弥漫性大B细胞淋巴瘤患者预后

2012-06-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Cancer Cell：弥散性大B细胞淋巴瘤协同性化疗新进展

2012-06-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Science：细胞内随机性竞争决定B细胞命运

2012-01-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

利妥昔单抗联合苯达莫司汀或可治疗侵袭性B细胞淋巴瘤

2011-08-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

病例报道:原发纵隔大B细胞淋巴瘤一例

2010-09-14

科室
- - 订阅+
  - 更多科室
工具
服务